Rita Mukhtar, MD
Associate Professor
Surgery
School of Medicine

Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.

• Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy.
  Breast cancer research and treatment 2024 Jacob S, Christofferson A, Fisch S, Norwood P, Castillo P, Yu H, Hirst G, Soliman H, Nanda R, Mukhtar RA, Ewing C, Majure M, Melisko M, Rugo HS, Esserman L, Price E, Chien AJ
• Reply to: "Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB)".
  Breast cancer research and treatment 2024 Kaur M, Rothschild HT, Mukhtar RA
• Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast.
  Breast cancer research and treatment 2024 Falade IO, Switalla KM, Baxter ME, Quirarte A, Record H, Rothschild HT, Clelland EN, Mukhtar RA
• Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.
  Journal of Clinical Oncology 2024 Alexandra Thomas, Denise M. Wolf, Ronald Balassanian, Yunn-Yi Chen, Julia Ye, Poonam Vohra, Evin H. Gulbahce, Alexander D. Borowsky, Lamorna Brown Swigart, Gillian L. Hirst, Sara Venters, Rita Nanda, …
• Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
  Annals of surgical oncology 2024 Tchou J, Gottipati S, Goldbach M, Baxter M, Venters S, Balassanian R, Vohra P, Gonzalves D, Ahmad Z, Nayak A, Boughey JC, Mukhtar RA, Chen YY
• Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.
  NPJ breast cancer 2024 Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A
• ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
  Annals of surgical oncology 2024 Switalla KM, Boughey JC, Mukhtar RA
• ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.
  Annals of surgical oncology 2024 Clelland EN, Mukhtar RA
• International survey on invasive lobular breast cancer identifies priority research questions.
  NPJ breast cancer 2024 Oesterreich S, Pate L, Lee AV, Chen F, Jankowitz RC, Mukhtar R, Metzger O, Sikora MJ, Li CI, Sotiriou C, Shah OS, Koorman T, Ulaner G, Reis-Filho JS, Davidson NM, Van Baelen K, Hutcheson L, Freeney S,…
• Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
  Annals of surgical oncology 2024 Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, …
• Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
  Annals of surgical oncology 2024 Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak…
• Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.
  Annals of surgical oncology 2024 Clelland EN, Quirarte A, Rothschild HT, Kaur M, Mujir F, Record H, Wong JM, Mukhtar RA
• Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.
  Journal of Clinical Oncology 2024 Erin Frances Cobain, Lajos Pusztai, Cathy Lynne Graham, Pat W. Whitworth, Peter D. Beitsch, Cynthia R. C. Osborne, Rakhshanda Layeequr Rahman, Nathalie MCDOWELL Johnson, Adam Brufsky, Reshma L. …
• Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.
  Journal of Clinical Oncology 2024 Roberto Antonio Leon-Ferre, Katrina Dimitroff, Christina Yau, Karthik Giridhar, Rita A. Mukhtar, Gillian L. Hirst, Nola Hylton, W. Fraser Fraser Symmans, Matthew P. Goetz, Laura Esserman, Judy …
• The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes.
  Surgical Oncology Insight 2024 Alison S. Baskin, Laura A. Huppert, Tatiana Kelil, Lisa Singer, Rita A. Mukhtar
• Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.
  Journal of Clinical Oncology 2024 Alexandra Thomas, Denise M. Wolf, Ronald Balassanian, Yunn-Yi Chen, Julia Ye, Poonam Vohra, Evin H Gulbahce, Alexander D. Borowsky, Lamorna Brown Swigart, Gillian L. Hirst, Sara Venters, Rita Nanda, …
• I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).
  Journal of Clinical Oncology 2024 Amy Jo Chien, Rita A. Mukhtar, Karthik Giridhar, Olufunmilayo I. Olopade, Kevin Kalinsky, Christos Vaklavas, Anthony D. Elias, Mei Wei, Matthew P. Goetz, Laura van 't Veer, Silver Alkhafaji, Hope S. …
• Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
  Seminars in oncology 2024 Corso G, Fusco N, Guerini-Rocco E, Leonardi MC, Criscitiello C, Zagami P, Nicolò E, Mazzarol G, La Vecchia C, Pesapane F, Zanzottera C, Tarantino P, Petitto S, Bianchi B, Massari G, Boato A, Sibilio A…
• ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.
  Annals of surgical oncology 2024 Falade I, Mukhtar RA
• Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
  Annals of surgical oncology 2024 Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Wong J, Foster R, Mukhtar RA
• Abstract PO4-02-03: Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2- Invasive Lobular Carcinoma – A FLEX sub study.
  Cancer Research 2024 Rita Mukhtar, Christina Yau, Denise Wolf, Adam Brufsky, Hannah Linden, Natasha Hunter, Reshma Mahtani, Abirami Sivapiragasam, Trevor Feinstein, Fengting Yan, Ian Grady, Priscilla McAuliffe, Michaela …
• Abstract PO5-26-07: Surgery for Invasive Lobular Carcinoma: A Patient Experience Survey from the Lobular Breast Cancer Alliance.
  Cancer Research 2024 Laurie Hutcheson, Janice Axelrod, Tracy Cushing, Colleen Fitzwater, Rinath Jeselsohn, Gitte Joergensen, Maria Karsten, Miranda Kimm, Megan Kruse, Theresa Langdon, Julia Levine, Mason Mitchell-Daniels,…
• Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.
  NPJ breast cancer 2024 Alkhafaji S, Wolf DM, Magbanua MJM, J van 't Veer L, Park JW, Esserman L, Mukhtar RA
• Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy.
  Cancer Research 2024 Nadine Goldhammer, Shruti Warhadpande, Liana Beld, Cristian K. Maldonado Rodas, Allison Lam, Tam Binh Bui, Shoko Emily Abe, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, …
• Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.
  Advances in radiation oncology 2024 Chen JJ, Zhu I, Patel A, Krings G, Chen YY, Yuen F, Mukhtar RA, Melisko M, Singer L, Park CC, Prionas ND
• Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk.
  Cell stem cell 2024 Northey JJ, Hayward MK, Yui Y, Stashko C, Kai F, Mouw JK, Thakar D, Lakins JN, Ironside AJ, Samson S, Mukhtar RA, Hwang ES, Weaver VM
• ASO Visual Abstract: Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
  Annals of surgical oncology 2024 Parmeshwar N, Dugan CL, Barnes LL, Cheng JK, Patterson AK, Miller A, Mukhtar R, Piper M
• Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
  Breast cancer research and treatment 2023 Schwartz CJ, Khorsandi N, Blanco A, Mukhtar RA, Chen YY, Krings G
• ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
  Annals of surgical oncology 2023 Ramalingam K, Clelland E, Rothschild H, Mujir F, Record H, Kaur M, Mukhtar RA
• Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.
  NPJ breast cancer 2023 Record H, Clelland E, Rothschild HT, Kaur M, Chien AJ, Melisko M, Rugo HS, Mujir F, Huppert L, Mukhtar RA
• Letter to the Editor of Annals of Surgical Oncology concerning "Is Choosing Wisely Wise for Lobular Carcinoma in Patients over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns".
  Annals of surgical oncology 2023 Mukhtar RA, Huppert L, Ramalingam K
• The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).
  Breast cancer research and treatment 2023 Rothschild HT, Clelland EN, Abel MK, Chien AJ, Shui AM, Esserman L, Khan SA, Mukhtar RA
• 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study.
  Annals of Oncology 2023 S. Gottipati, H.M. Earl, C. Yau, D.A. Cameron, J. Abraham, L. Hayward, F. Reyal, M. Osdoit, G.S. Sonke, J. Wesseling, J. Boughey, M.P. Goetz, A. DeMichele, L. Pusztai, P. Sharma, M. Martin Jimenez, S.…
• Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.
  Journal of clinical and translational science 2023 Rothschild HT, Jo Chien A, Jankowitz RC, Magbanua MJ, Mouabbi JA, Shatsky RA, Levine J, Mukhtar RA
• Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
  Annals of surgical oncology 2023 Parmeshwar N, Dugan CL, Barnes LL, Cheng JK, Patterson AK, Miller A, Mukhtar R, Piper M
• ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma.
  Annals of surgical oncology 2023 Ramalingam K, Mukhtar R
• Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
  Annals of surgical oncology 2023 Ramalingam K, Clelland E, Rothschild H, Mujir F, Record H, Kaur M, Mukhtar RA
• Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 Kaur M, Patterson A, Molina-Vega J, Rothschild H, Clelland E, Ewing CA, Mujir F, Esserman LJ, Olopade OI, Mukhtar RA
• Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
  Breast cancer research and treatment 2023 Clelland EN, Rothschild HT, Patterson A, Molina-Vega J, Kaur M, Symmans WF, Schwartz CJ, Chien AJ, Benz CC, Mukhtar RA
• The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.
  Research square 2023 Rothschild HT, Clelland EN, Abel MK, Chien AJ, Shui AM, Esserman L, Khan SA, Mukhtar RA
• Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
  Annals of surgical oncology 2023 Rothschild HT, Clelland EN, Mujir F, Record H, Wong J, Esserman LJ, Alvarado M, Ewing C, Mukhtar RA
• ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.
  Annals of surgical oncology 2023 Rothschild HT, Mukhtar RA
• Editorial: Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancer.
  European journal of radiology 2023 Jochelson MS, Mukhtar RA
• Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
  Annals of surgical oncology 2023 Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, …
• Metabolic Positron Emission Tomography in Breast Cancer.
  PET clinics 2023 Cecil K, Huppert L, Mukhtar R, Dibble EH, O'Brien SR, Ulaner GA, Lawhn-Heath C
• Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.
  Annals of surgery 2023 Mukhtar RA, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, Yu H, Ding Q, Dugan CL, Sheade J, Crown A, Carr M, Wong J, Son J, Yang R, Chan T, Terando A, Alvarado M, Ewing C, Tonneson J, Tamirisa N, …
• Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-Reply.
  JAMA surgery 2023 Mukhtar RA, Yau C, Esserman LJ
• Time to Surgery in Breast Cancer-Is Faster Always Better?
  JAMA surgery 2023 Mukhtar RA, Esserman LJ
• 407 Moving from observational studies to a clinical trial: the impact of obesity and surgical weight loss on breast imaging, tissue, and cancer screening experience: the B-BRITE study.
  Journal of Clinical and Translational Science 2023 Elle N Clelland, Judy Gonzalez-Vargas, Sarah G Palilla, Suneil K Koliwad, Heather I Greenwood, Christopher J Schwartz, Chris C. Benz, Diana L Alba, Rita A Mukhtar
• 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression.
  Journal of Clinical and Translational Science 2023 Harriet T Rothschild, A Jo Chien, Rachel C Jankowitz, Mark JM Magbanua, Jason A Mouabbi, Rebecca A Shatsky, Julia Levine, Rita A Mukhtar
• HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
  Breast cancer research and treatment 2023 Rothschild HT, Clelland E, Patterson A, Molina-Vega J, Kaur M, Symmans WF, Schwartz CJ, Chien AJ, Mukhtar RA
• Abstract HER2-14: HER2-14 HER-2 low status in early stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
  Cancer Research 2023 Harriet T. Rothschild, Elle Clelland, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, Mary Kathryn Abel, W. Fraser Symmans, Christopher J. Schwartz, Rita Mukhtar
• Abstract P2-03-16: Quantifying estrogen and progesterone receptor status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
  Cancer Research 2023 Elle Clelland, Harriet T. Rothschild, Anne Patterson, Julissa Molina-Vega, Mandeep Kaur, Mary Kathryn Abel, W. Fraser Symmans, Jo Chien, Christopher J. Schwartz, Rita Mukhtar
• Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP).
  Cancer Research 2023 Jennifer Rosenbluth, Christopher J. Schwartz, Tam Binh Bui, Shruti Warhadpande, Pravin Phadatare, Sigal Eini, Michael Bruck, Julissa Molina-Vega, Kami Pullakhandam, Nicole Schindler, Lamorna A. Brown …
• Abstract P6-05-10: An international survey on invasive lobular breast cancer (ILC) reveals gaps in knowledge and top priority research areas.
  Cancer Research 2023 Steffi Oesterreich, Leigh Pate, ADRIAN V. LEE, Rachel C. Jankowitz, Patrick Derksen, Rita Mukhtar, Otto Metzger, Matthew J. Sikora, Christopher Li, Christos Sotiriou, Gary Ulaner, Jorge Reis-Filho, …
• Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival.
  Cancer Research 2023 Mandeep Kaur, Anne Patterson, Julissa Molina-Vega, Harriet T. Rothschild, Elle Clelland, Mary Kathryn Abel, Laura J. Esserman, Olufunmilayo I. Olopade, Rita Mukhtar
• Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 Schwartz CJ, Ruiz J, Bean GR, Sirohi D, Joseph NM, Hosfield EM, Jacobs TW, Mukhtar RA, Chen YY, Krings G
• Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.
  Plastic and reconstructive surgery. Global open 2023 Barnes LL, Foster R, Mukhtar RA, Esserman LJ, Ewing C, Alvarado M, Wong J, Piper M
• Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.
  Cancer research communications 2022 Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky AD, Esserman LJ
• Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.
  American journal of surgery 2022 Conroy PC, Mohamedaly S, Karimzada M, Brian R, Im C, Hernandez S, Roman S, Hirose K, Mukhtar R, Kirkwood K, O'Sullivan P, Alseidi A
• ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
  Annals of surgical oncology 2022 Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
• Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.
  JAMA surgery 2022 Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, …
• Hereditary vs Sporadic Invasive Lobular Carcinoma and Impact of Locoregional Therapy on Disease-Free Survival.
  Journal of the American College of Surgeons 2022 Alison S Baskin, Anne K Patterson, Amie M Blanco, Julie S Mak, Rita A Mukhtar
• Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.
  Surgical oncology clinics of North America 2022 Goodman K, Abel MK, Lawhn-Heath C, Molina-Vega J, Jones EF, Mukhtar RA
• See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency.
  Global Surgical Education - Journal of the Association for Surgical Education 2022 Tasce Bongiovanni, Elizabeth Lancaster, Hannah Decker, Rita A. Mukhtar, Marisa Schwab, Jeanette Broering, Patricia O’Sullivan, Kenzo Hirose, Elizabeth Wick
• The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
  Annals of surgical oncology 2022 Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
• ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.
  Annals of surgical oncology 2022 Abel MK, Mukhtar RA
• Abstract LB021: Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer progression.
  Cancer Research 2022 Jason J. Northey, Yoshihiro Yui, Mary-Kate Hayward, Connor Stashko, FuiBoon Kai, Janna Mouw, Dhruv Thakar, Jonathon Lakins, Alastair Ironside, Susan Samson, Rita Mukhtar, E. Shelley Hwang, Valerie …
• Pathologic complete response (pCR) rates for HR+/HER2- breast cancer by molecular subtype in the I-SPY2 Trial.
  Journal of Clinical Oncology 2022 Laura Ann Huppert, Hope S. Rugo, Lajos Pusztai, Rita A. Mukhtar, Amy Jo Chien, Christina Yau, Denise M. Wolf, Donald A. Berry, Laura van 't Veer, Douglas Yee, Angela DeMichele, Laura Esserman
• Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply.
  JAMA oncology 2022 Mukhtar R, Symmans WF, Esserman LJ
• Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership.
  The Journal of surgical research 2022 Greenberg AL, Sullins VF, Donahue TR, Sundaram VM, Saldinger PF, Divino CM, Anton NE, Stefanidis D, Reilly LM, Egan RJ, Beals CKJ, Riall TS, Duh QY, Mukhtar RA, Hirose K, Lebares CC
• Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast cancer.
  Cancer Research 2022 A. Jo Chien, Kevin M Kalinsky, Julissa Molina-Vega, Rita Mukhtar, Karthik Giridhar, Olufunmilayo I Olopade, Amrita Basu, Smita M Asare, Paul Henderson, Gillian Hirst, Ruixiao Lu, Ella Jones, Nola …
• Abstract P2-02-02: Differences in levels of circulating tumor cells (CTC) and disseminated tumor cells (DTC) in early-stage lobular versus ductal breast cancer.
  Cancer Research 2022 Silver Alkhafaji, Denise Wolf, Mark Magbanua, Laura Van 't Veer, John Park, Laura J. Esserman, Rita A. Mukhtar
• Abstract P3-02-01: Initial experience of FES-dedicated breast PET imaging of early-stage ER+ invasive lobular carcinoma.
  Cancer Research 2022 Ella F Jones, Deep K Hathi, Natalia Konovalova, Julissa Molina-Vega, David C Newitt, Courtney Lawhn-Heath, Kimberly M Ray, Bonnie N Joe, Diane Heditsian, Susie Brain, A. Jo Chien, Laura J Esserman, …
• Abstract P3-02-02: FES-dedicated breast PET uptake in early-stage ER+ breast cancers.
  Cancer Research 2022 Ella F. Jones, Deep K. Hathi, Julissa Molina-Vega, David C. Newitt, Courtney Lawhn-Heath, Kimberly M. Ray, Bonnie N. Joe, Diane Heditsian, Susie Brain, Rita A. Mukhtar, A. Jo Chien, Hope S. Rugo, …
• Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL.
  Cancer Research 2022 Anika Christofferson, Elissa Price, Rita A Mukhtar, Amrita Basu, Laura Esserman, A Jo Chien
• The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study.
  NPJ breast cancer 2021 Abel MK, Shui AM, Melisko M, Chien AJ, Yoshida EJ, Lancaster EM, Van 't Veer L, Esserman LJ, Mukhtar RA
• O13 BIOLOGIC VERSUS SYNTHETIC MESH IN VENTRAL HERNIA REPAIR: PARTICIPANT-LEVEL ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS AT ONE YEAR.
  British Journal of Surgery 2021 Naila Dhanani, Oscar Olavarria, Kyung Hyun Lee, Charlotte Young, Frank Primus, Rita Mukhtar, Julie Holihan, Mike Liang, Hobart Harris
• Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.
  Breast cancer research and treatment 2021 Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA
• Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
  NPJ breast cancer 2021 Abel MK, Melisko ME, Rugo HS, Chien AJ, Diaz I, Levine JK, Griffin A, McGuire J, Esserman LJ, Borno HT, Mukhtar RA
• Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
  NPJ breast cancer 2021 Yee D, Isaacs C, Wolf DM, Yau C, Haluska P, Giridhar KV, Forero-Torres A, Jo Chien A, Wallace AM, Pusztai L, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Kemmer K, Yung RL, …
• Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief.
  NPJ breast cancer 2021 Khoury AL, Keane H, Varghese F, Hosseini A, Mukhtar R, Eder SE, Weinstein PR, Esserman LJ
• Correction to: Applications of 3D printing in breast cancer management.
  3D printing in medicine 2021 Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T
• Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
  American journal of surgery 2021 Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA
• Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.
  Journal of Clinical Oncology 2021 Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, Amy Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura Esserman, Hala Borno, Rita A. Mukhtar
• Early onset, multiple, bilateral fibroadenomas of the breast: a case report.
  BMC women's health 2021 Im CJ, Miller A, Balassanian R, Mukhtar RA
• Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions.
  Current Breast Cancer Reports 2021 Rita A. Mukhtar, A. Jo Chien
• Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.
  Annals of surgery 2021 Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H, Young DM, Hansen S
• Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors.
  Breast cancer research and treatment 2021 Tang A, Cohan CM, Hansen KS, Beattie G, Greenwood HI, Mukhtar RA
• ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.
  Annals of surgical oncology 2021 Mukhtar RA, Boughey JC
• Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
  Annals of surgical oncology 2021 Mukhtar RA, Hoskin TL, Habermann EB, Day CN, Boughey JC
• Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.
  NPJ breast cancer 2021 Abel MK, Greenwood H, Kelil T, Guo R, Brabham C, Hylton N, Wong J, Alvarado M, Ewing C, Esserman LJ, Boughey JC, Mukhtar RA
• Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS.
  Cancer Research 2021 Heather Greenwood, Rita Freimanis, Case Brabham, Rita Mukhtar, Gillian Hirst, Paul Kim, April Liang, Laura Esserman, Nola Hylton, Amrita Basu
• Abstract PD6-08: DCE-MRI derived imaging features for characterizing invasive lobular breast cancer and predicting recurrence-free survival after neoadjuvant therapy.
  Cancer Research 2021 Geraldine Tran, Ella Jones, Wen Li, Kelly Fahrner-Scott, David Newitt, Bonnie Joe, Laura Esserman, Nola Hylton, Rita Mukhtar
• Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up.
  Cancer Research 2021 Case Brabham, Rita Mukhtar, April Liang, Paul Kim, Gillian Hirst, Amrita Basu, Heather Greenwood, Rita Freimanis, Alexander Borowsky, Shelley Hwang, Rick Baehner, Gregor Krings, Nola Hylton, Laura …
• Abstract PS17-05: Relationship between body mass index and tumor subtype by menopausal status: An analysis in women with lobular carcinoma of the breast.
  Cancer Research 2021 Harriet Rothschild, Laura Esserman, Christopher Benz, Rita Mukhtar
• Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
  Breast (Edinburgh, Scotland) 2021 Scheepens JCC, Veer LV', Esserman L, Belkora J, Mukhtar RA
• Applications of 3D printing in breast cancer management.
  3D printing in medicine 2021 Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T
• A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021 Hansen KS, Ghersin H, Piper M, Tavakol M, Lee B, Esserman LJ, Roberts JP, Freise C, Ascher NL, Mukhtar RA
• Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.
  The breast journal 2021 Mukhtar RA, Brabham CE, Guo R, Abel MK, Wong J, Ewing C, Esserman LJ, Alvarado M
• Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.
  The Journal of clinical investigation 2020 Northey JJ, Barrett AS, Acerbi I, Hayward MK, Talamantes S, Dean IS, Mouw JK, Ponik SM, Lakins JN, Huang PJ, Wu J, Shi Q, Samson S, Keely PJ, Mukhtar RA, Liphardt JT, Shepherd JA, Hwang ES, Chen YY, …
• Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.
  Annals of surgical oncology 2020 Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA
• 274 Poster Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials.
  European Journal of Cancer 2020 M.K. Abel, I. Diaz, J. Levine, L. Pate, E. Viggiano, M. Melisko, R. Mukhtar
• Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.
  Breast cancer research and treatment 2020 Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA
• Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.
  American journal of surgery 2020 Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA
• Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.
  Cancers 2020 Jones EF, Hathi DK, Freimanis R, Mukhtar RA, Chien AJ, Esserman LJ, Van't Veer LJ, Joe BN, Hylton NM
• 4314 The Impact of Axillary Surgery on Recurrence-Free Survival in Invasive Lobular Carcinoma (ILC) of the Breast.
  Journal of Clinical and Translational Science 2020 Mary Kathryn Reed Abel, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Catherine Park, Rita A. Mukhtar
• Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast.
  Journal of Clinical Oncology 2020 Ruby Guo, Case E. Brabham, Kelly Fahrner-Scott, Mary Kathryn Abel, Jasmine Wong, Michael Alvarado, Laura Esserman, Cheryl Ann Ewing, Rita A. Mukhtar
• Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
  Breast cancer research and treatment 2020 Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H
• Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry.
  Cancer Research 2020 Jane M Wei, Paul Kim, Cheryl Ewing, Jasmine Wong, Laura J Esserman, Michael D Alvarado, Abimbola O Olusanya, Skye Stewart, Ashley Tydon, Parima Daroui, Jeffrey V Kuo, Hannah L Park, Karen T Lane, …
• Abstract P3-08-16: The impact of residual ductal carcinoma in situ on breast cancer recurrence in the neoadjuvant I-SPY2 TRIAL.
  Cancer Research 2020 Marie Osdoit, Christina Yau, W. Fraser Symmans, Judy C. Boughey, Smita M. Asare, Ron Balassanian, Jodi M. Carter, Yunn-Yi Chen, Kimberly Cole, Laila Khazai, Molly Klein, Dina Kokh, Gregor Krings, …
• Abstract P4-13-01: Trends in primary management of invasive lobular carcinoma: An analysis of the National Cancer Database (NCDB).
  Cancer Research 2020 Rita A Mukhtar, Tanya L. Hoskin, Elizabeth B. Habermann, Judy C. Boughey
• Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study.
  Cancer Research 2020 Thomas O'Keefe, Christina Yau, Eliza Jeong, Emma Iaconetti, Paul Kim, Ann Griffin, Joseph McGuire, Rita Mukhtar, Laura Esserman, Olivier Harismendy, Gillian L. Hirst
• Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy.
  Cancer Research 2020 Paul Kim, Heather I. Greenwood, Rita I. Freimanis, Gillian L Hirst, Megan Fischer-Colbrie, Jessica Gibbs, Nola M Hylton, Christina Yau, Eun-Sil Shelley Hwang, Laura J. Esserman, Rita A Mukhtar
• Abstract PD9-08: Accuracy of ultrasound in evaluating response to neoadjuvant therapy in invasive lobular carcinoma of the breast.
  Cancer Research 2020 Kelly Fahrner-Scott, Jasmine M Wong, Merisa Piper, Cheryl Ewing, Michael Alvarado, Laura J Esserman, Nola Hylton, Rita A Mukhtar
• Pragmatic Trials and Approaches to Transforming Care.
  2020 Peter G. Stock, Rita Mukhtar, Hila Ghersin, Allison Stover Fiscalini, Laura Esserman
• Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.
  Journal of the American College of Surgeons 2019 Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS
• Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.
  NPJ breast cancer 2019 Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA
• Editorial: Applying Margin Consensus Guidelines to Invasive Lobular Carcinoma of the Breast.
  Annals of surgical oncology 2019 Mukhtar RA
• Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
  AJR. American journal of roentgenology 2019 Greenwood HI, Wong JM, Mukhtar RA, Alvarado MD, Price ER
• Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
  NPJ breast cancer 2019 Jones EF, Ray KM, Li W, Chien AJ, Mukhtar RA, Esserman LJ, Franc BL, Seo Y, Pampaloni MH, Joe BN, Hylton NM
• Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications.
  Plastic and reconstructive surgery. Global open 2019 Mukhtar RA, Holland M, Sieber DA, Wen KW, Rugo HS, Kadin ME, Bean GR
• Abstract 118: The Impact of Post-Operative Prophylactic Antibiotics in Immediate 2-Stage Prepectoral Breast Reconstruction.
  Plastic & Reconstructive Surgery Global Open 2019 Michael Holland, Rachel Lentz, Clara Gomez-Sanchez, Jami Rothman, Jasmine Wong, Rita Mukhtar, Hani Sbitany
• Changes in mammographic density following bariatric surgery.
  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2019 Hosseini A, Khoury AL, Varghese F, Carter J, Wong JM, Mukhtar RA
• Abstract P1-15-15: Accuracy of MRI after neoadjuvant therapy for invasive lobular carcinoma of the breast.
  Poster Session Abstracts 2019 KE Fahrner-Scott, JM Wong, M Piper, C Ewing, M Alvarado, LJ Esserman, N Hylton, RA Mukhtar
• Abstract P4-11-01: A simple intervention for long-term relief of chronic post mastectomy pain.
  Poster Session Abstracts 2019 HJ Keane, AL Khoury, A Hosseini, FP Varghese, R Mukhtar, SE Eder, J Wong, LJ Esserman
• Abstract P6-01-04: Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
  Poster Session Abstracts 2019 EF Jones, KM Ray, R Mukhtar, W Li, BL Franc, LJ Esserman, BN Joe, MH Pampaloni, NM Hylton
• Abstract PD7-06: Molecular subtypes of invasive lobular breast cancer in the I-SPY2 TRIAL.
  Cancer Research 2019 Z Zhu, C Yau, AJ Chien, T Haddad, LJ Esserman, L van't Veer, RA Mukhtar
• Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
  NPJ breast cancer 2019 Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda…
• Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents.
  JAMA surgery 2018 Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, Esserman L, Mukhtar R, Finlayson E
• ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
  Annals of surgical oncology 2018 Mukhtar RA
• Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
  NPJ breast cancer 2018 Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J,…
• Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
  Annals of surgical oncology 2018 Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, Sbitany H, Alvarado M, Foster R, Ewing C, Esserman L
• 452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast.
  European Journal of Cancer 2018 M. Mamounas, J. Wong, K. Fahrner-Scott, Y.Y. Chen, G. Krings, C. Ewing, L. Esserman, M. Alvarado, H. Rugo, R. Mukhtar
• Abstract P2-12-16: The use of oncoplastic surgical techniques to increase successful breast conservation in invasive lobular carcinoma of the breast.
  Poster Session Abstracts 2018 JM Wong, ML Piper, C Ewing, M Alvarado, LJ Esserman, H Sbitany, RD Foster, RA Mukhtar
• Abstract P5-12-04: The impact of bariatric surgery on mammographic breast density.
  Poster Session Abstracts 2018 A Hosseini, AL Khoury, J Carter, JM Wong, MD Alvarado, C Ewing, LJ Esserman, RA Mukhtar
• Abstract P5-22-22: Breast tumor location in BRCA mutation carriers and implications for prevention.
  Poster Session Abstracts 2018 A Hosseini, LJ Esserman, AM Wallace, A Au, RA Mukhtar
• Breast tumor location in BRCA mutation carriers and implications for prevention.
  Journal of Clinical Oncology 2017 Ava Hosseini, Laura Esserman, Anne M. Wallace, Amal Khoury, Alfred Au, Rita Mukhtar
• Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
  Breast cancer research and treatment 2016 Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L
• The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016 Mukhtar RA, Piper ML, Freise C, Van't Veer LJ, Baehner FL, Esserman LJ
• How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.
  World journal of clinical cases 2015 Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ
• Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.
  Journal of the National Comprehensive Cancer Network : JNCCN 2015 Mukhtar RA, Wong JM, Esserman LJ
• Abstract PD1-5: Characterizing the Tumor Immune MicroEnvironment (TIME) in high-risk ductal carcinoma in situ.
  Poster Discussion Abstracts 2015 Michael J Campbell, Rita Mukhtar, Ekene Obi-Okoye, Booyeon Han, Vickram Tandon, Sarah Zheng, Zelos Zhu, Max Endicott, Max Wicha, Linda Lindstrom, Alfred Au, Frederick Baehner, Joe Gray, Laura Esserman
• Abstract 165: Suppressed immunity and macrophages characterize high risk high grade DCIS.
  Tumor Biology 2014 Michael J. Campbell, Rita Mukhtar, Ekene Obi-Okoye, Booyeon Han, Vick Tandon, Sarah Zheng, Zelos Zhu, Max Endicott, Max Wicha, Linda Lindstrom, Alfred Au, Frederick Baehner, Joe Gray, Laura Esserman
• The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.
  PloS one 2013 Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ
• Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
  Annals of surgical oncology 2013 Mukhtar RA, Yau C, Rosen M, Tandon VJ, I-SPY 1 TRIAL and ACRIN 6657 Investigators, Hylton N, Esserman LJ
• Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
  Breast cancer research and treatment 2012 Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E, I-SPY TRIAL …
• Biology of breast cancer in Nigerian women: a pilot study.
  Annals of African medicine 2012 Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ
• Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
  Annals of surgical oncology 2012 Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ
• P1-06-10: Lobular Breast Cancer and NAC: Combined Results from the NKI and I-SPY 1 Trial.
  Poster Session Abstracts 2011 RA Mukhtar, E Lips, J Wesseling, C Livasy, C Yau, D Berry, L van't Veer, LA Carey, LJ Esserman, S Rodenhuis, ES Hwang
• P4-09-19: PCNA+ Tumor Associated Macrophages Are Associated with M1 and M2 Gene Expression, and Confer Poor Prognosis in the Absence of Anti-Tumor Immune Environment.
  Poster Session Abstracts 2011 R Mukhtar, D Wolf, V Tandon, J Zhu, M Lenburg, Veer L van't, MJ Campbell
• PD02-05: MRI Phenotype and Tumor Subtype Affect Breast Conservation Eligibility and MRI Accuracy in the I-SPY 1 Trial.
  Poster Discussion Abstracts 2011 RA Mukhtar, N Hylton, M Rosen
• Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
  Breast cancer research and treatment 2011 Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ
• Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness.
  Journal of Clinical Oncology 2011 R. Mukhtar, A. P. Moore, V. Tandon, O. Nseyo, A. Au, F. L. Baehner, C. A. Adisa, N. Eleweke, O. I. Olopade, D. H. Moore, M. Campbell, L. Esserman
• Benign Thoracic Disease in the Elderly.
  Cardiothoracic Surgery in the Elderly 2011 Rita A. Mukhtar, Pierre R. Theodore
• Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.
  Expert review of molecular diagnostics 2011 Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ
• Abstract P2-09-11: Response of Invasive Lobular Cancers to Neoadjuvant Therapy.
  Poster Session Abstracts 2010 RA Mukhtar, ES Hwang, C Livasy, LJ. Esserman
• Evaluation of levels of proliferating macrophages in patients at a county hospital and those with early recurrences.
  Journal of Clinical Oncology 2010 R. Mukhtar, A. Moore, O. Nseyo, A. Au, F. L. Baehner, D. H. Moore, M. Campbell, L. Esserman
• Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence.
  Journal of pediatric surgery 2009 Mukhtar RA, Baskin LS, Stock PG, Lee H
• Bacteriologic features of surgical site infections following breast surgery.
  American journal of surgery 2009 Mukhtar RA, Throckmorton AD, Alvarado MD, Ewing CA, Esserman LJ, Chiu C, Hwang ES
• Benign thoracic disease in the elderly.
  Thoracic surgery clinics 2009 Mukhtar RA, Theodore PR
• Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.
  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 2009 Mukhtar RA, Kattan OM, Harris HW
• Image of the month--quiz case. Traumatic intramuscular cyst of the duodenum.
  Archives of surgery (Chicago, Ill. : 1960) 2005 Spitzer AL, Mukhtar RA, Harris HW
• Quality-of-life issues in psoriasis.
  Dermatologic clinics 2004 Mukhtar R, Choi J, Koo JY